CIK: 0001892134
Total reported value
$3.9B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ARQT | Arcutis Biotherapeutics INC | Stock-Other | 13.84% | -1.71% | — | |
| 2 | PHAT | Phathom Pharmaceuticals INC | Stock-Other | 6.76% | -1.99% | — | |
| 3 | MIRM | Mirum Pharmaceuticals INC | Stock-Other | 6.69% | +3.83% | — | |
| 4 | ✓ | Sierra Oncology INC Com | Stock-Other | 6.40% | — | — | |
| 5 | KRYS | Krystal Biotech INC | Stock-Healthcare | 4.91% | -0.03% | — | |
| 6 | ✓ | Imago Biosciences INC | Stock-Other | 4.88% | — | — | |
| 7 | PCVX | Vaxcyte INC | Stock-Other | 4.75% | — | — | |
| 8 | SNDX | Syndax Pharmaceuticals INC | Stock-Other | 4.73% | — | — | |
| 9 | 290A | Chinook Therapeutics INC | Stock-Other | 3.78% | — | — | |
| 10 | OPHTEUR | Iveric Bio INC | Stock-Other | 3.47% | — | — | |
| 11 | NVLSEUR | Alpine Immune Sciences INC | Stock-Other | 3.20% | — | — | |
| 12 | VRDN | Viridian Therapeutics INC | Stock-Other | 2.74% | — | — | |
| 13 | CRNX | Crinetics Pharmaceuticals In | Stock-Other | 2.65% | — | — | |
| 14 | BCYC | Bicycle Therapeutics Plc-adr | Stock-Other | 2.26% | — | — | |
| 15 | TARS | Tarsus Pharmaceuticals INC | Stock-Other | 2.03% | -0.28% | — | |
| 16 | 4XC1 | Kalvista Pharmaceuticals INC | Stock-Other | 1.97% | +0.38% | — | |
| 17 | ANAB | Anaptysbio INC | Stock-Other | 1.90% | — | — | |
| 18 | 2JQ | Gritstone Bio INC | Stock-Other | 1.84% | — | — | |
| 19 | COGT | Cogent Biosciences INC | Stock-Other | 1.69% | — | — | |
| 20 | ARVN | Arvinas INC | Stock-Other | 1.55% | — | — | |
| 21 | 1T7 | Tricida INC | Stock-Other | 1.46% | — | — | |
| 22 | SLN | Silence Therapeutics Plc-adr | Stock-Other | 1.43% | — | — | |
| 23 | ✓ | Merus N V | Stock-Other | 1.42% | — | — | |
| 24 | AUTL | Autolus Therapeutics PLC | Stock-Other | 1.33% | -0.09% | — | |
| 25 | ✓ | Passage Bio INC | Stock-Other | 1.32% | — | — | |
| 26 | ✓ | Pardes Biosciences INC Com | Stock-Other | 1.28% | — | — | |
| 27 | ✓ | Frazier Lifesciences Acqu Co | Stock-Other | 1.28% | — | — | |
| 28 | NTLA | Intellia Therapeutics INC | Stock-Other | 1.26% | — | — | |
| 29 | STRO | Sutro Biopharma, Inc. | Stock-Other | 1.24% | — | — | |
| 30 | TYRA | Tyra Biosciences INC | Stock-Other | 1.21% | — | — | |
| 31 | REPL | Replimune Group INC | Stock-Other | 1.04% | — | — | |
| 32 | ✓ | Gracell Biotechnologies-adr | Stock-Other | 0.68% | — | — | |
| 33 | ACRS | Aclaris Therapeutics INC | Stock-Other | 0.60% | +0.48% | NEW | |
| 34 | ✓ | Avadel Pharmaceuticals PLC | Stock-Other | 0.55% | — | — | |
| 35 | ✓ | Molecular Templates Inc | Stock-Other | 0.40% | — | — | |
| 36 | EPIEUR | Essa Pharma INC | Stock-Other | 0.36% | — | — | |
| 37 | ✓ | Aptinyx INC | Stock-Other | 0.36% | — | — | |
| 38 | IMVT | Immunovant INC | Stock-Other | 0.28% | — | — | |
| 39 | SRRK | Scholar Rock Holding CORP | Stock-Other | 0.17% | — | — | |
| 40 | CERE1EUR | Cerevel Therapeutics Holding | Stock-Other | 0.17% | — | — | |
| 41 | EPZMEUR | Epizyme INC | Stock-Other | 0.07% | — | — | |
| 42 | ✓ | Nabriva Therapeutics PLC | Stock-Other | 0.02% | — | — |